Trandolapril and Verapamil Hydrochloride (Glenmark Pharmaceuticals Inc., USA)
Welcome to the PulseAid listing for the Trandolapril and Verapamil Hydrochloride drug offered from Glenmark Pharmaceuticals Inc., USA. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Glenmark Pharmaceuticals Inc., USA |
NON-PROPRIETARY NAME: | Trandolapril and Verapamil Hydrochloride |
SUBSTANCE NAME: | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-02-25 |
END MARKETING DATE: | 0000-00-00 |
Trandolapril and Verapamil Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Trandolapril and Verapamil Hydrochloride from Glenmark Pharmaceuticals Inc., USA |
LABELER NAME: | Glenmark Pharmaceuticals Inc., USA |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1; 240(mg/1; mg/1) |
START MARKETING DATE: | 2015-02-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68462-294_df1a0c56-7e3d-488e-a3df-e3a5937823c9 |
PRODUCT NDC: | 68462-294 |
APPLICATION NUMBER: | ANDA079135 |
Other TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: